EHRA Premium Access

Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.

Congress Presentation

About the speaker

Associate Professor Kars Neven

Alfried-Krupp-Hospital Ruttenscheid, Essen (Germany)
1 presentation
0 follower

10 more presentations in this session

Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)

Speaker: Doctor R. Tieleman (Groningen, NL)


Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation

Speaker: Doctor S. Chen (Frankfurt, DE)


Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Speaker: Professor J. Mansourati (Brest, FR)


Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

Speaker: Miss D. Mlayeh (Aulnay sous Bois, FR)


Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.

Speaker: Ms N. Kaehler (Berlin, DE)


Access the full session

Poster session 1 - Atrial Fibrillation - Stroke Prevention

Speakers: Associate Professor K. Neven, Doctor R. Tieleman, Doctor S. Chen, Professor J. Mansourati, Miss D. Mlayeh...

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb